Clinical trial
Urinary Bactericidal Activity of 4 Doses of Levofloxacin (250, 500, &750, and 1000 mg) Against Fluoroquinolone-Resistant E. Coli
NCT00376376 is registered in ClinicalTrials.gov with Michigan State University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Urinary Bactericidal Activity of 4 Doses of Levofloxacin (250, 500, &750, and 1000 mg) Against Fluoroquinolone-Resistant E. Coli
- Lead sponsor
- Michigan State University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2006
- Completion date
- November 30, 2006
- Enrollment
- 10
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy volunteers